Anavex Life Sciences Corp (AVXL)

[JB3729]

Dr. Missling compared valuations too. Makes sense to compare -

Dr. De - Give our readers 5 reasons investors would be interested in AVXL.

CEO Christopher Missling -

1.Alzheimer's disease is a significant unmet need since no cure has been found yet.

2.ANAVEX 2-73 and pipeline targets novel mechanism of action further "upstream" of the Alzheimer's disease pathology by targeting Sigma-1 receptor and muscarinic receptors, which is believed to increase cellular plasticity and reduce oxidative stress, inflammation, abeta generation and tau hyperphosphorylation. All these effects are believed to be relevant to reduce Alzheimer's disease pathology.

3.Safety profile of ANAVEX 2-73 is clean based on Phase 1 and interim Phase 2a data.

4.Anavex management team and Scientific Advisory Board, consisting of Alzheimer's disease experts like Jeff Cummings, Paul Aisen, Norm Relkin.

5.Valuation still very attractive compare to AXON.